Article Details
Retrieved on: 2025-08-08 11:58:22
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Clesrovimab is the second RSV monoclonal antibody preventive for babies on the US market, available alongside nirsevimab. WHO issues target ...
Article found on: www.cidrap.umn.edu
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here